PHASE-II TRIAL OF CARACEMIDE (NSC-253272) IN ADVANCED UNRESECTABLE NON-SMALL-CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY

被引：7
|
作者：
LAD, T
SCHOR, J
MULLANE, M
CARROLL, R
CHERNICOFF, D
BLOUGH, R
WEIDNER, L
机构：
[1] UNIV ILLINOIS,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60680
[2] W SIDE VET AFFAIRS MED CTR,CHICAGO,IL
[3] CHICAGO OSTEOPATH MED CTR,CHICAGO,IL
来源：
INVESTIGATIONAL NEW DRUGS | 1992年 / 10卷 / 01期
关键词：
PHASE-II; CARACEMIDE; NON-SMALL-CELL LUNG CANCER;
D O I：
10.1007/BF01275475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF CYCLOPHOSPHAMIDE AND HEXAMETHYLMELAMINE IN NON-OAT CELL BRONCHOGENIC-CARCINOMA
    PISONI, MB
    LIBRETTI, A
    PIAZZA, E
    VAGO, G
    SCAPATICCI, R
    BIANCHI, C
    TOMIROTTI, M
    SCANNI, A
    CALZAVARA, MP
    CASSANI, L
    SCARPAZZA, G
    MARSONI, S
    MORASCA, L
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 731 - 732
  • [22] PHASE-II TRIAL OF MENOGARIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - AN ILLINOIS CANCER COUNCIL TRIAL
    LOCKER, GY
    KILTON, L
    HOELTGEN, T
    KNOP, RH
    BENSON, AB
    CHERNICOFF, D
    BARRETT, J
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 871 - 872
  • [23] PHASE-II STUDIES ON WEEKLY CISPLATINUM PLUS EPIRUBICIN OR ETOPOSIDE IN THE TREATMENT OF ADVANCED NON-SMALL CELL BRONCHOGENIC-CARCINOMA
    LELLI, G
    GIULIOTTI, C
    MARTONI, A
    PANNUTI, F
    CASADIO, M
    GIORDANI, S
    STROCCHI, E
    CHEMIOTERAPIA, 1986, 5 (04): : 228 - 231
  • [24] PHASE-II EVALUATION OF MITOXANTRONE IN PATIENTS WITH BRONCHOGENIC-CARCINOMA - A SOUTHEASTERN-CANCER-STUDY-GROUP TRIAL
    KRAMER, BS
    GAMS, R
    BIRCH, R
    EINHORN, L
    BUCHANAN, R
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1295 - 1296
  • [25] PHASE-II TRIAL OF PIROXANTRONE IN ADVANCED NON-SMALL-CELL CARCINOMA OF THE LUNG - A SOUTHWEST ONCOLOGY GROUP-STUDY
    WILLIAMSON, SK
    CROWLEY, JJ
    LIVINGSTON, R
    HANTEL, A
    DOROSHOW, JH
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 29 - 30
  • [26] A RANDOMIZED PHASE-II STUDY OF META-AMSA (NSC-249992) AND NEOCARZINOSTATIN (NSC-157365) IN NON-SMALL CELL BRONCHOGENIC-CARCINOMA - AN EASTERN-COOPERATIVE-GROUP-STUDY
    ETTINGER, DS
    DAY, R
    FERRARO, JA
    RUCKDESCHEL, JC
    WOLL, JE
    CREECH, RH
    VOGL, SE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02): : 167 - 170
  • [27] CARBOPLATIN AND VINBLASTINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    DOLL, D
    GOUTSOU, M
    GRAZIANO, S
    ELLERTON, J
    BITRAN, J
    MODEAS, C
    HERNDON, J
    PERRY, M
    GREEN, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 29 (01) : 71 - 74
  • [28] A PHASE-II STUDY OF VM26 IN PREVIOUSLY TREATED PATIENTS WITH SMALL CELL BRONCHOGENIC-CARCINOMA (SCC)
    PEDERSEN, AG
    OSTERLIND, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 241 - 241
  • [29] PHASE-II STUDY OF ESORUBICIN IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA AND NO PRIOR CHEMOTHERAPY - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    HOELTGEN, T
    KILTON, L
    KRAUSS, S
    MCNAMARA, M
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 765 - 766
  • [30] A PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN UNRESECTABLE NON-SMALL-CELL LUNG-CANCER
    SMIT, EF
    BERENDSEN, HH
    PIERS, DA
    SMEETS, J
    RIVA, A
    POSTMUS, PE
    BRITISH JOURNAL OF CANCER, 1992, 65 (03) : 405 - 408
12345